/Ca
2ϩ exchanger in failing hearts may be a compensatory mechanism to promote influx and efflux of Ca 2ϩ , despite impairment of the sarcoplasmic reticulum (SR). To explore this, we monitored intracellular calcium (Ca i 2ϩ ) and cardiac function in mouse hearts engineered to overexpress the Na ϩ /Ca 2ϩ exchanger and subjected to ischemia and hypoxia, conditions known to impair SR Ca i 2ϩ transport and contractility. Although baseline Ca i 2ϩ and function were similar between transgenic and wild-type hearts, significant differences were observed during ischemia and hypoxia. During early ischemia, Ca i 2ϩ was preserved in transgenic hearts but significantly altered in wild-type hearts. Transgenic hearts maintained 40% of pressure-generating capacity during early ischemia, whereas wild-type hearts maintained only 25% (P Ͻ 0.01). During hypoxia, neither peak nor diastolic Ca i 2ϩ decreased in transgenic hearts. In contrast, both peak and diastolic Ca i 2ϩ decreased significantly in wild-type hearts. The decline of Ca i 2ϩ was abbreviated in hypoxic transgenic hearts but prolonged in wild-type hearts. Peak systolic pressure decreased by nearly 10% in hypoxic transgenic hearts and Ͼ25% in wild-type hearts (P Ͻ 0.001). These data demonstrate that enhanced gene expression of the Na ϩ /Ca 2ϩ exchanger preserves Ca i 2ϩ homeostasis during ischemia and hypoxia, thereby preserving cardiac function in the acutely failing heart. ischemia; hypoxia; sodium; calcium; heart failure; excitationcontraction UPREGULATION OF NA ϩ /CA 2ϩ EXCHANGE in the failing heart may be a compensatory adaptive mechanism to promote influx and efflux of cytostolic Ca 2ϩ , despite failure-associated defects in sarcoplasmic reticulum (SR) intracellular calcium (Ca i 2ϩ ) transport (10, 39, 43) . Under basal conditions, Ca i 2ϩ homeostasis is maintained primarily via release and uptake by the SR and secondarily by flux across the sarcolemma dominated by Na ϩ /Ca 2ϩ exchange. The predominant mode of the Na ϩ /Ca 2ϩ exchanger supplements the SR Ca 2ϩ -ATPase to decrease cell Ca 2ϩ and facilitate cardiac relaxation; whether the Na ϩ /Ca 2ϩ exchanger may provide a source of Ca 2ϩ to trigger SR calcium release and support the inotropic capacity of the heart (26, 28, 47) remains controversial. Several studies (5, 17, 34, 39, 43) have demonstrated downregulation of SR function in the failing heart that may, in part, contribute to alterations in Ca i 2ϩ , reduced tension development, and a blunted force-frequency relation in heart failure (8, 12, 18, 40) . Gene expression of the cardiac Na ϩ /Ca 2ϩ exchanger, however, is enhanced in failing human hearts (10, 43) , perhaps as a compensatory adaptation to assist impaired SR Ca i 2ϩ resequesteration during relaxation (10, 39, 43) or to boost inotropy by increasing Ca i 2ϩ influx during the action potential (10, 27, 31, 43) . Data from a recent study in dogs (39) indicate that a greater fraction of Ca i 2ϩ removal is attributable to Na ϩ /Ca 2ϩ exchange than to SR uptake in failing myocytes. Na ϩ /Ca 2ϩ exchange current density and contraction amplitude were significantly increased in cells from infarcted rabbit hearts (27) , suggesting that increased activity of the Na ϩ /Ca 2ϩ exchanger may promote Ca i 2ϩ entry and enhance SR Ca i 2ϩ loading and release in the damaged heart. Bers et al. (7) demonstrated that, in the absence of a functional SR, Na ϩ / Ca 2ϩ exchange might promote Ca i 2ϩ entry to activate contractility if intracellular sodium is sufficiently elevated. Because of concomitant alterations in genetic expression of other Ca 2ϩ handling proteins (11, 16, 35, 39, 43) , the functional significance of enhanced gene expression of the Na ϩ /Ca 2ϩ exchanger in mediating alterations in Ca i 2ϩ and myocardial function in the failing heart remains speculative. The availability of transgenic mice engineered to have specific enhanced gene expression of the cardiac Na ϩ /Ca 2ϩ exchanger (1) provides an opportunity to investigate the effects of increased abundance of the exchanger on Ca i 2ϩ release and uptake (45) in the absence of other pathological genetic perturbations. We recently developed a technique for simultaneously assessing Ca i 2ϩ and left ventricular (LV) function in the isovolumically contracting mouse heart to describe alterations in Ca i 2ϩ with alterations in SR protein expression (15) and changes in Ca i 2ϩ and myocardial function during myocardial ischemia (14) . Accordingly, we applied this approach to test the hypothesis that transgenic overexpression of the Na ϩ /Ca 2ϩ exchanger may play a unique role in maintaining Ca i 2ϩ exchange and contractility during pathologies that are known to effect SR Ca i 2ϩ transport and excitation-contraction (E-C) coupling (2, 13, 21, 22, 29, 30, 32) . We found that hearts that overexpress the Na ϩ /Ca 2ϩ exchanger are significantly better able to maintain Ca i 2ϩ homeostasis while boosting myocardial function during ischemia and hypoxia. These results point to the functional relevance of upregulation of Na ϩ /Ca 2ϩ exchange in pathological settings where SR calcium transport mechanisms are impaired.
METHODS
Production of transgenic mice. Heterozygous transgenic mice were generated as previously described (1) . Adult male and female animals were used in the present study. The expression levels of Na ϩ /Ca 2ϩ exchanger in transgenic hearts was shown to be ϳ200% of controls as measured by 45 Ca 2ϩ uptake (1). We did not observe any grossly apparent altered phenotype in transgenic animals; the heart and body weights were not different between transgenic and wild-type animals, as has been previously reported (1) .
Isolated heart perfusion. Hearts from equal numbers of male and female wild-type and transgenic animals were perfused in vitro as previously described (14, 15) . Briefly, the aorta was slipped over a 20-gauge blunt-tipped stainless steel needle through which oxygenated (95% O 2 -5% CO 2 ) buffer [containing (in mmol/l) 118.0 NaCl, 4.7 KCl, 1.2 KH 2 PO 4 , 1.5 CaCl 2 , 1.2 MgCl 2 , 23.0 NaHCO 3 , 10.0 dextrose, and 0.3 EDTA; pH 7.4] was pumped at a rate of ϳ3 ml/min. An intraventricular balloon-catheter system specially designed for the mouse heart (14) was passed through the mitral annulus until seated in the LV, and the distal end of the balloon catheter was connected to a Statham P23B pressure transducer (Gould, Cleveland, OH) to record functional parameters. All in vitro studies were conducted at 30°C, and hearts were paced at ϳ6 Hz to minimize consumption of aequorin.
Measurement of Ca i 2ϩ . Ca i 2ϩ activity was monitored using aequorin, as previously described (14, 15) . Briefly, after modifying the perfusate to contain 0.5 mmol/l CaCl 2 , 0.6 mmol/l MgCl 2 , and 20 mmol/l dextrose, we injected 1-3 l of aequorin with a glass micropipette within 90 s into a localized region of 2 mm 2 at the apex of the heart. The heart was positioned in an organ bath such that the aequorin-loaded region was ϳ2 mm from the bottom of the bath. The Ca 2ϩ and Mg 2ϩ concentrations of the perfusate were restored to 2.5 mmol/l Ca 2ϩ and 1.2 mmol/l Mg 2ϩ in a step-wise fashion over a period of 40 min. The entire isolated heart preparation was positioned in a light-tight box for collection of the aequorin light signal, as described previously (14, 15) . Aequorin luminescence was detected by a photomultiplier tube and recorded as anodal current. For estimation of Ca i 2ϩ , Triton X-100 was injected into the coronary perfusate to quickly permeabilize the myocardial cell membranes and expose the remaining active aequorin to saturating Ca 2ϩ . This procedure results in a burst of light, the integral of which approximates the maximum light (L max ), against which light signals of interest (L) provided the fractional luminescence (L/L max ). L/L max was referred to a calibration equation to estimate Ca i 2ϩ (21) . Signal recording. After light was passed through a current discriminator, the light signal was filtered through an analog low-pass window (Ϫ6 dB at 25 Hz; 8-pole Bessel, UAF-41, Burr Brown, Tucson, AZ). The light signal and LV isovolumic pressure were then simultaneously recorded on a strip recorder (model 35-V704-10, Gould) and a digital oscilloscope (model 4094A, Nicolet Instruments, Madison, WI). Digitized LV pressure and light signals were stored every 0.2 ms on a disk recorder (model XF-44, Nicolet) connected to the oscilloscope. LV pressure recordings were analyzed with regard to peak systolic pressure, end-diastolic pressure, and peak rates of pressure development and decline. The time constant of pressure decay, P , was calculated using a nonlinear leastsquares technique to solve the equation LVP(t) ϭ (LVP o Ϫ LVP a )e Ϫt/P ϩ LVP a (36) , where LVP o is the measured LV pressure (LVP) corresponding to the peak negative pressure derivative with respect to time (dP/dt min ), t is time, and LVP a is the pressure 10% above the measured minimum diastolic pressure. Aequorin light signals, which were converted to Ca i 2ϩ estimates, were analyzed with regard to diastolic and peak systolic Ca i 2ϩ . The time constant of the decline of Ca i 2ϩ signal, L90 Ϫ 10% (where 90 and 10 are the percent light signal), was calculated with a modified method of Bers and Berlin (6, 50) . Briefly, the digitized data from 90 to 10% of the peak in the decline phase of the aequorin light signal were fitted with the formula Ca i 2ϩ ϭ (C o Ϫ C a )e Ϫt/L90Ϫ10% ϩ C a (50) . We defined C a as the minimum diastolic light and C o as the initial light at the beginning of the decline. Values of L90 Ϫ 10% were calculated using a nonlinear least-squares technique. Time constants of decline from 90 to 50% ( L90 Ϫ 50% ) and from 50 to 10% ( L50 Ϫ 10% ) of the Ca i 2ϩ signal were also calculated.
In vitro ischemia. After a 15-min equilibrium period, we recorded baseline conditions in 10 transgenic and 10 wildtype hearts. The hearts were then subjected to no-flow global ischemia by the abrupt termination of power to the pump. The organ bath was evacuated of oxygenated solution and refilled with nitrogen saturated-perfusate maintained at 30°C. Pacing at 6 Hz was maintained during ischemia. During ischemia, the aequorin light signals were time averaged each individual minute interval and for the first 5-min interval from the onset of ischemia.
In vitro hypoxia. After a 15-min equilibrium period, we recorded baseline conditions in 10 transgenic and 10 wildtype hearts. Hypoxia was induced by an abrupt change of buffer solution from one bubbled with a gaseous mixture of 95% O 2 -5% CO 2 to one bubbled with 95% N 2 -5% CO 2 (PO 2 Ͻ 15 mmHg; see Ref. 30) . No other conditions were altered, including the temperature and the pH, during this exchange. After 10 min of hypoxia, we recorded the functional and Ca i 2ϩ indexes.
Cyanide perfusion. After a 15-min equilibrium period, we recorded baseline conditions in five transgenic and five wildtype hearts. Cyanide inhibition of oxidative phosphorylation was accomplished by changing the perfusate to one containing 0.5 mmol/l KCN (20) and 4.2 mmol/l K ϩ . The buffer was not bubbled, and the temperature and buffer pH were maintained. After 10 min of perfusion with cyanide-containing perfusate, we recorded the functional indexes.
Statistics. Data are represented as the means Ϯ SE. Comparisons between transgenic and wild-type hearts were per-formed using Student's t-test for unpaired observations. Comparisons between baseline and ischemia, hypoxia, or perfusion with cyanide were performed using Student's t-test for paired observations.
RESULTS

Baseline measurements of Ca i
2ϩ and functional parameters of isolated hearts from wild-type and transgenic mice are summarized in Table 1 . Peak and diastolic Ca i 2ϩ were similar in the two groups of hearts. Differences in the decline of the Ca i 2ϩ transient were apparent when we compared L90 Ϫ 50% (transgenic 29 Ϯ 4 ms and wild type 44 Ϯ 4 ms; P Ͻ 0.05), suggesting an enhanced effectiveness of Ca i 2ϩ extrusion by Na ϩ /Ca 2ϩ exchange at baseline (50) . There was a trend for increased peak LV systolic (LVSP) and end-diastolic pressures (LVEDP) as well as an increased peak positive pressure derivative with respect to time (dP/dt max ) and dP/dt min , although these differences were not significant. Ventricular relaxation, as reflected by P , was faster (P Ͻ 0.05) in transgenic hearts (13 Ϯ 1 ms) than in wild-type hearts (17 Ϯ 1 ms).
Effects of ischemia. When coronary flow was interrupted, there was an abrupt fall in LV pressure in all hearts. During the first minute of ischemia, the decline in LVSP was significantly attenuated in transgenic hearts, whereas the decline in LVEDP was comparable between groups. Developed pressure fell to zero by 3 min in both groups of hearts. However, whereas LVSP was depressed to 25 Ϯ 2% of baseline in wild-type hearts after 1 min of ischemia, transgenic hearts maintained 40 Ϯ 3% of their ability to generate pressure through 1 min of no-flow ischemia (n ϭ 10, P Ͻ 0.01). Figure 1 illustrates strip-chart recordings of LV pressure in a wild-type and transgenic heart during the early moments of no-flow ischemia. Superimposing the profiles of the decline in function illustrates the relative preservation of function in the transgenic hearts during early no-flow ischemia.
We measured the aequorin light signals during 1-min intervals after interruption of flow to the heart. When coronary flow was interrupted, there were abrupt alterations in Ca i 2ϩ in wild-type hearts, whereas Ca i 2ϩ was relatively preserved in transgenic hearts, as reflected by the relative preservation of the aequorin light signals. After 1 min of ischemia, the peak of the aequorin light signal increased slightly (104 Ϯ 4% of baseline) in transgenic hearts but decreased to 83 Ϯ 3% of baseline in wild-type hearts (P Ͻ 0.01). The diastolic light signal was unchanged in transgenic hearts after 1 min of ischemia, whereas it increased to 121 Ϯ 11% of baseline in wild-type hearts (P Ͻ 0.05). After 2 min of ischemia, the peak light in transgenic hearts retained 91 Ϯ 3% of baseline, whereas in wild-type hearts the peak light was depressed to 71 Ϯ 8% of baseline (P Ͻ 0.05). During the second minute of ischemia, the diastolic light signal decreased to 84 Ϯ 4% of baseline in transgenic hearts but remained above baseline in wild-type hearts (P Ͻ 0.05, wild-type vs. transgenic). Subsequently, the diastolic light signal increased in both groups of hearts but did not exceed baseline in transgenic hearts until after 5 min of ischemia. Figure 2A illustrates the percent change of the aequorin light signal amplitude (the difference between peak and diastolic light) during ischemia in wild-type and transgenic hearts. Whereas the amplitude of the Ca i 2ϩ transients remained nearly constant throughout the first 5 min of ischemia in Values are presented as means Ϯ SE; n ϭ 10 hearts in each group. Ca i 2ϩ , intracellular Ca 2ϩ ; 90 Ϫ 10% , 90 Ϫ 50% , and 50 Ϫ 10% , time constants of decline from 90 to 10%, 90 to 50%, and 50 to 10%, respectively, of the peak aequorin light signal; LV, left ventricular; LVSP, LV peak systolic pressure; LVEDP, LV end-diastolic pressure; LV dP/dt max , peak positive pressure derivative with respect to time; LV dP/dt min , peak negative pressure derivative with respect to time; P , time constant of decline of LV pressure from time at dP/dt min ; NS, not significant. transgenic hearts, it degenerated more rapidly in wildtype hearts between 1 and 4 min. Figure 2B illustrates the cumulative average of aequorin light signals recorded during 5 min of no-flow ischemia. Whereas distinct transients remain discernible in transgenic hearts, the transients have degenerated in wild-type hearts. The relative preservation of function ( Fig. 1) and Ca i 2ϩ (Fig. 2) in transgenic hearts suggests that greater abundance of Na ϩ /Ca 2ϩ exchangers in the transgenic hearts may contribute to their ability to maintain systolic and diastolic function under conditions of ischemic stress.
Effects of hypoxia. The perfusate and organ bath were switched to buffer bubbled with 95% N 2 -5% CO 2 for 10 min. Figure 3 summarizes the percent decline from baseline of functional parameters after 10 min of hypoxia in wild-type hearts and hearts that overexpress the Na ϩ /Ca 2ϩ exchanger. In wild-type hearts, functional indexes were significantly decreased during hypoxia compared with baseline, resulting in nearly a one-third reduction in the ability of the hearts to generate pressure. In transgenic hearts, however, the functional impairment during hypoxia was less pronounced. For example, peak LVSP decreased by barely 10% during hypoxia in transgenic hearts, whereas in wild-type hearts the reduction exceeded 28% (P Ͻ 0.001). Ca i 2ϩ was also significantly less affected by hypoxia in transgenic hearts. Figure 3B summarizes the percent changes from prehypoxia conditions of the Ca i 2ϩ transient after 10 min of hypoxia. In transgenic hearts, neither peak Ca i 2ϩ (0.81 Ϯ 0.04 M) nor diastolic Ca i 2ϩ (0.35 Ϯ 0.05 M) changed significantly during hypoxia. In wild-type hearts, however, peak changed significantly during hypoxia in transgenic hearts, whereas both peak and diastolic Ca i 2ϩ significantly decreased in wild-type hearts. L90 Ϫ 10% was relatively briefer during hypoxia in transgenic hearts but was significantly prolonged in wild-type hearts, most prominently during the terminal phase. Means Ϯ SE from 8 hearts in each group are shown. Fig. 2 . A: amplitude (difference between peak and minimum) of the aequorin light signal during no-flow ischemia in wild-type and transgenic hearts (n ϭ 10 hearts in each group). The amplitudes represent the time averages of amplitudes recorded for 1-min intervals subsequent to interruption of perfusion of the heart, and the percentage of baseline is the comparison to the amplitude of the signal recorded just before interruption of perfusion of the heart. Symbols and error bars represent mean values Ϯ SE. The amplitude of the light signal in wild-type compared with transgenic hearts was significantly depressed through 5 min of ischemia. *P Ͻ 0.05. After 5 min of ischemia, the amplitudes of the light signals were not quantitatively different between groups. B: aequorin light signals continuously recorded and averaged by the oscilloscope for 5 min in a wild-type and transgenic heart during no-flow ischemia. Whereas light signals remained distinct throughout several minutes of ischemia in the transgenic heart, they degenerated rapidly in the wild-type heart. Ca i 2ϩ decreased from 0.82 Ϯ 0.02 M at baseline to 0.70 Ϯ 0.02 M (P Ͻ 0.01), and diastolic Ca i 2ϩ decreased from 0.35 Ϯ 0.05 to 0.25 Ϯ 0.04 M (P Ͻ 0.01) after 10 min of hypoxia. Moreover, the time course of the decline of the Ca i 2ϩ transients tended to accelerate during hypoxia in transgenic hearts. In wild-type hearts, however, the decline of the Ca i 2ϩ signal was prolonged. Whereas L90 Ϫ 10% was prolonged to 127 Ϯ 13% of baseline in wild-type hearts, it was abbreviated to 83 Ϯ 5% of baseline in transgenic hearts (P Ͻ 0.05) during hypoxia (Fig. 3) . The most prominent difference was in the terminal phase of the decline of the Ca i 2ϩ transient, reflected by 50 Ϫ 10 , which was significantly prolonged to 39 Ϯ 8 ms in wild-type but shortened to 21 Ϯ 2 ms in transgenic hearts (P Ͻ 0.05) during hypoxia. Figure 4 illustrates simultaneous recordings of aequorin light signals and LV pressure in a wildtype and transgenic heart at baseline and after 10 min of hypoxia. In the transgenic heart, the peak of the aequorin light signal, representing peak Ca i 2ϩ , did not change significantly, and the decline of the transient was more rapid during hypoxia than at baseline. LV pressure did not change significantly. In the wild-type heart, the peak of the aequorin signal was significantly decreased, and the decline of the transient was slightly prolonged during hypoxia. The relative preservation of function with concomitant preservation of the Ca i 2ϩ signal in transgenic hearts compared with wild-type hearts suggest enhanced effectiveness of both Ca 2ϩ influx and efflux by the increased number of Na ϩ /Ca 2ϩ exchangers, which become more relevant under conditions of hypoxic stress. In contrast, in wild-type hearts, functional and Ca i 2ϩ indexes are depressed during hypoxia.
Effects of cyanide perfusion. The perfusate and organ bath were switched to buffer containing cyanide, which inhibits oxidative phosphorylation in both the surface and core cells (30) . In wild-type and transgenic hearts, cyanide perfusion depressed LV function to a greater extent than during hypoxia. Transgenic hearts, however, generated significantly higher systolic pressure than wild-type hearts (36 Ϯ 3 vs. 22 Ϯ 8 mmHg, P Ͻ 0.05) after 10 min of perfusion with cyanide. In wildtype hearts, peak LVSP decreased by 64 Ϯ 5%, whereas in transgenic hearts, peak LVSP decreased by 22 Ϯ 4% (P Ͻ 0.05). LVEDP was higher (P ϭ 0.07) in transgenic hearts (32 Ϯ 7 mmHg) than in wild-type hearts (15 Ϯ 2 mmHg) after 10 min of cyanide perfusion. In three transgenic hearts, pressure alternans was observed during cyanide perfusion, whereas in the wild-type hearts, pressure alternans was not apparent.
DISCUSSION
Our results demonstrate that enhanced gene expression of the Na ϩ /Ca 2ϩ exchanger preserves Ca i 2ϩ homeostasis under conditions of ischemic and hypoxic stress, thereby attenuating contractile dysfunction. These findings, in transgenic mouse hearts engineered to have increased abundance of the Na ϩ /Ca 2ϩ exchanger, point to the functional relevance of upregulation of the Na ϩ /Ca 2ϩ exchanger in pathological settings where SR calcium exchange mechanisms are impaired. The present findings indicate that hearts with upregulation of the Na ϩ /Ca 2ϩ exchanger demonstrate preserved peak systolic Ca i 2ϩ during ischemia and hypoxia and more rapid removal of Ca i 2ϩ during hypoxia than wild-type hearts. The inotropic and lusitropic properties of the myocardium were better preserved during ischemia and hypoxia in hearts with increased expression of the Na ϩ /Ca 2ϩ exchanger. The benefits of enhanced gene expression of the Na ϩ /Ca 2ϩ Fig. 4 . Aequorin light signals (top) and isovolumic LVP waveforms (bottom) from a wild-type (left) and transgenic heart (right) at baseline conditions (solid lines) and after 10 min of perfusion with 95% N 2 -5% CO 2 (dashed lines). In the wild-type heart, hypoxia resulted in a decrease in the Ca i 2ϩ signal and a corresponding decrease in LVP. In the transgenic heart, neither Ca i 2ϩ nor LVP was reduced by hypoxia. Moreover, the decline of Ca i 2ϩ was accelerated during hypoxia in transgenic hearts.
exchanger in settings where SR calcium transport mechanisms are defective may include Ca i 2ϩ removal and entry to sustain myocardial function.
The Na ϩ /Ca 2ϩ exchanger is a major Ca i 2ϩ efflux mechanism during myocardial relaxation. Its capacity to function in the reverse mode, promoting sarcolemmal Ca i 2ϩ entry, has also been described but most conspicuously as a phenomenon during ischemia and reperfusion (23, 37, 44) . Evidence is accumulating, however, that demonstrates that, under basal conditions, the Na ϩ /Ca 2ϩ exchanger may operate in the Ca i 2ϩ influx mode to increase SR Ca i 2ϩ content and contribute to contractility (7, 9, 26) . The lack of consensus on this point may be partly ascribed to the different cell preparations and species studied. Indeed, a recent report by Terracciano et al. (45) describes how, during the latter part of the decline in the Ca i 2ϩ transient, the Na ϩ /Ca 2ϩ exchanger reverses and brings Ca 2ϩ into mouse ventricular myocytes. Moreover, transgenic overexpression of the Na ϩ /Ca 2ϩ exchanger resulted in a significant increase in the SR Ca i 2ϩ content of mouse ventricular myocytes (45) , which may have contributed to their faster rate of Ca i 2ϩ release and uptake (50) . In view of reports of enhanced Na ϩ / Ca 2ϩ exchange in the failing myocardium (10, 39, 43) , examination of Ca i 2ϩ dynamics and function in mice engineered to overexpress the exchanger provides an opportunity for understanding its functional importance in the damaged heart.
Under baseline conditions, we found no differences in peak systolic or diastolic Ca i 2ϩ levels between wildtype and transgenic hearts overexpressing the Na ϩ / Ca 2ϩ exchanger, which is consistent with previous studies using this model (1, 45, 50) . We found that the rate of decline of Ca i 2ϩ , especially in the terminal phase, is accelerated in transgenic hearts, suggesting an enhanced effectiveness of Ca i 2ϩ extrusion by Na ϩ / Ca 2ϩ exchange (50) . Our measurement of P in transgenic hearts (Table 1) suggests that faster extrusion of Ca i 2ϩ may have a functional correlate under baseline conditions. These results confirm previous findings in transgenic ventricular myocytes (1, 45, 50) , in which faster relaxation was ascribed to the increased abundance of Na ϩ /Ca 2ϩ exchangers operating in the forward mode to extrude Ca i 2ϩ . Molecular studies of this transgenic model (45, 50) have reported no differences in other SR calcium regulatory proteins.
The mechanisms of early ischemic contractile failure are numerous and include ionic, energetic, and mechanical pathways (4) . With interruption of a glucoserich perfusate to the heart, the vasculature collapses and a complex set of ionic and metabolic changes in the intracellular milieu of the cardiac myocyte ensues. It is generally agreed that the abrupt decline of LV pressure is largely a consequence of the loss of turgor of the perfused coronary vasculature (22) . However, ATP decreases and hydrogen ions and inorganic phosphates increase immediately upon interruption of myocardial perfusion. H ϩ decreases SR Ca i 2ϩ release by alterations in the activity of the Ca i 2ϩ release channel. Acidic pH inhibits Ca i 2ϩ binding to myofibrillar troponin C, thereby reducing actomyosin ATPase activation and force generation. The evolving metabolic acidosis is believed to impair SR calcium transport during the early phase of myocardial ischemia, contributing to the decrease in force development (2) . With prolonged ischemia, increasing acidosis as well as depressed levels of ATP impair the ability of the SR to resequester Ca i 2ϩ , such that diastolic Ca i 2ϩ increases during ischemia (21, 32) . During hypoxia as well, accumulation of intracellular inorganic phosphates and H ϩ may contribute to contractile depression (2, 13, 21) . As in no-flow ischemia, alterations of the action potential, changes in Ca i 2ϩ transport by the SR, and a decrease in the responsiveness of the myofilaments to Ca i 2ϩ contribute to contractile dysfunction during hypoxia (13) . When the internal pH of cardiac cells is lowered, as occurs during ischemia and hypoxia, Na ϩ /H ϩ exchange becomes the major regulatory system by which cells recover from acidosis (25) . Accumulation of H ϩ has been shown to mediate a rise in Na ϩ by activation of the Na ϩ /H ϩ exchanger (3, 25) . Inhibition of the Na ϩ /K ϩ -ATPase activity during hypoxia markedly increases Na ϩ accumulation (3). The resultant net increase in intracellular Na ϩ during ischemia and hypoxia is thought to provoke Ca i 2ϩ influx via reverse transport of the Na ϩ / Ca 2ϩ exchanger in efforts to alleviate Na ϩ loading (37, 38) . In fact, it was recently demonstrated that the reverse mode of Na ϩ /Ca 2ϩ exchange accounts for the largest contribution to Ca i 2ϩ accumulation in anoxic cardiomyocytes (24) .
Our measurements of Ca i 2ϩ and function during ischemia and hypoxia are consistent with the above described sequelae. Our results demonstrate that, during the first minute of ischemia, while LV pressure decreased 75% from baseline, there was a 20% decrease in peak Ca i 2ϩ accompanied by an increase in diastolic Ca i 2ϩ in wild-type hearts. During the second minute of ischemia, the diastolic Ca i 2ϩ returned to baseline, but peak Ca i 2ϩ remained depressed. Subsequent ischemia resulted in progressive increases in peak Ca i 2ϩ toward preischemic values and significant increases in diastolic Ca i 2ϩ above baseline. These observations are consistent with the notion that early contractile failure during ischemia may, in part, be a consequence of impaired SR Ca i 2ϩ release and that protracted ischemia leads to reduced SR Ca i 2ϩ uptake. Analyses of digitized pressure recordings indicated some evidence of arrhythmias, which may have contributed to the rise in diastolic calcium during ischemia. In transgenic hearts, LV function decreased 60% from baseline during the first minute of ischemia, whereas peak Ca i 2ϩ did not change. Peak Ca i 2ϩ decreased only slightly during the second minute of ischemia and remained significantly greater than peak Ca i 2ϩ in wild-type hearts throughout 5 min of ischemia (Fig. 2) . In transgenic hearts, diastolic Ca i 2ϩ did not change during the first minute of ischemia and decreased during the second minute of ischemia. Yao et al. (50) P NMR in the same transgenic model, reported comparable decreases in myocardial ATP levels and pH during ischemia in wild-type and transgenic hearts. Accordingly, our data suggest that reduced diastolic Ca i 2ϩ and preserved peak Ca i 2ϩ during ischemia in transgenic hearts were a consequence of a greater abundance of Na ϩ /Ca 2ϩ exchangers operating in the forward mode and the reverse mode. A previous study (9) indicated that overexpression of the Na ϩ / Ca 2ϩ exchanger increased susceptibility to ischemia and reperfusion injury, more prominently in male hearts, perhaps due to sustained Ca i 2ϩ influx during ischemia or increased Ca i 2ϩ overload upon reperfusion. Interestingly, however, we found that, during early ischemia, the amplitudes of the Ca i 2ϩ signals were greatest in the female transgenic hearts (data not shown).
During hypoxia, peak Ca i 2ϩ decreased by 15%, and functional indexes decreased by ϳ25% in wild-type hearts. Diastolic Ca i 2ϩ significantly decreased in wildtype hearts, but LVEDP did not change. Moreover, L90 Ϫ 10% was prolonged during hypoxia in wild-type hearts, but P was unchanged. In transgenic hearts, neither peak nor diastolic Ca i 2ϩ decreased during hypoxia. During hypoxia, L90 Ϫ 10% was significantly abbreviated in transgenic hearts, suggesting an enhanced effectiveness of Ca i 2ϩ extrusion by Na ϩ /Ca 2ϩ exchange (50) . The preservation of Ca i 2ϩ in hearts overexpressing the Na ϩ /Ca 2ϩ exchanger was paralleled by better preservation of function compared with wildtype hearts, in which both Ca i 2ϩ and function were depressed during hypoxia (Fig. 3) . Previous studies (3, 24, 38) have shown that intracellular Na ϩ loading during hypoxia is the driving force behind Ca 2ϩ influx via Na ϩ /Ca 2ϩ exchange. Our current observations, then, suggest that, during hypoxia and as in ischemia, preservation of systolic and diastolic Ca i 2ϩ in transgenic hearts was a consequence of a greater number of Na ϩ /Ca 2ϩ exchangers operating in both the reverse and forward modes.
We (14) have previously shown that, in vitro, Ca i 2ϩ exchange during no-flow ischemia may be sustainable in the small mouse heart by oxygen that diffuses epicardially into the myocardium (14) . Accordingly, despite efforts to minimize the partial pressure of oxygen in the buffer, hypoxia may still have promoted generation of ATP by aerobic metabolism. To exclude the effects of inhomogeneous oxygen tensions within hearts or between groups of hearts, we studied the effects of metabolic inhibition by cyanide, which inhibits oxidative phosphorylation in both surface and core cells. Chemical hypoxia with cyanide-containing perfusate resulted in a much more profound depression in cardiac function than did hypoxia induced by 95% N 2 -5% CO 2 -bubbled perfusate. Yet the extent of systolic dysfunction in transgenic hearts was significantly blunted compared with wild-type hearts during cyanide perfusion, suggesting that the increased abundance of Na ϩ /Ca 2ϩ exchangers in the transgenic hearts may contribute to their ability to generate pressure despite uniform inhibition of oxidative phosphorylation. The increases in diastolic pressure with cyanide were larger in transgenic hearts. Because more complete inhibition of oxidative phosphorylation would further impair SR calcium reuptake, the observations in transgenic hearts are consistent with a greater abundance of Na ϩ /Ca 2ϩ exchangers working in the reverse mode during cyanide perfusion. The occurrence of pressure alternans in transgenic hearts might indicate greater Ca i 2ϩ influx. More profound changes in membrane stability and/or ion homeostasis imposed by cyanide intoxication (19, 20) may also have contributed to the increased diastolic pressure in transgenic hearts.
Observations from hypoxic transgenic hearts indicate that, despite preservation of Ca i 2ϩ influx and efflux, there remains a significant (ϳ10%) depression of function, suggesting that reduced responsiveness of the myofilaments to Ca i 2ϩ substantially contributes to contractile failure in the mouse heart. Our findings from this transgenic model provide additional insight into the relative contributions of reduced Ca i 2ϩ availability and decreased Ca i 2ϩ myofilament sensitivity to contractile failure in hypoxic and ischemic myocardium. Reasoning that hypoxia-induced decreases in pH and ATP levels were comparable in transgenic and wild-type hearts, as was demonstrated in an NMR study of the same transgenic model during ischemia (9) , our data suggest that ϳ10% of the contractile failure is attributable to loss of Ca i 2ϩ myofilament responsiveness, and the additional ϳ15% of contractile failure observed in the wild-type hearts is attributable to the 15% reduction in peak Ca i 2ϩ . Likewise, the differences in Ca i 2ϩ and function observed provide additional insight into the question of the relative contribution of changes in Ca i 2ϩ to early ischemic contractile failure. In wild-type hearts, LV pressure decreased 75% during the first minute of ischemia, whereas the peak of the Ca i 2ϩ signal decreased Ͻ20%. In transgenic hearts, LV pressure decreased 60% during 1 min of ischemia, whereas peak Ca i 2ϩ was unchanged. These data infer that, in the mouse heart, nearly 20% of the reduction of the pressure-generating capability during the first minute of ischemia is a consequence of a reduction in peak Ca i 2ϩ . Moreover, assuming that during early no-flow ischemia the intracellular environment is similar to that occurring during hypoxia, we deduce that nearly 10% of the contractile failure during early ischemia may be attributable to reduced myofilament responsiveness to Ca i 2ϩ . Therefore, we propose that, in the mouse heart, the rapid loss of LV function during the first minute of no-flow ischemia is attributable to ϳ70% loss of turgor of the coronary vasculature, 20% to reduced levels of Ca i 2ϩ availability, and 10% to decreased Ca i 2ϩ myofilament sensitivity. Because absolute anoxia may not occur in the ischemic heart (42, 51), these observations could be relevant to human coronary disease, where coronary occlusion is often not complete.
In vivo and in vitro studies have shown that inhibiting Na ϩ /Ca 2ϩ exchange by inhibiting Na ϩ /H ϩ exchange reduces the occurrence of ischemia-induced ar-rhythmia (33, 41, 49) , suggesting that sarcolemmal influx of Ca i 2ϩ during ischemia affects E-C coupling. Moreover, interventions to block Ca 2ϩ influx during coronary artery occlusion have resulted in more severe ischemic dysfunction (46, 48) , despite improvements after reperfusion. A corollary to these observations may be that enhanced Ca 2ϩ influx and efflux during myocardial ischemia might attenuate ischemic dysfunction. To the best of our knowledge, this hypothesis has not been tested. In light of our findings, demonstrating better preservation of Ca i 2ϩ and function during hypoxia and ischemia in transgenic hearts, we propose that the ionic rearrangements that contribute to the sequelae of cardiac contractile failure may be less detrimental in the presence of enhanced gene expression of the Na ϩ /Ca 2ϩ exchanger. In summary, the results demonstrate that hearts with enhanced gene expression of the Na ϩ /Ca 2ϩ exchanger are significantly better able to maintain Ca i 2ϩ homeostasis while boosting myocardial function under conditions of ischemic or hypoxic stress and metabolic inhibition by cyanide. The data indicate the approximate contributions of vascular collapse, Ca i 2ϩ availability, and myofilament sensitivity to early ischemic contractile failure. Our findings suggest that enhanced gene expression of the Na ϩ /Ca 2ϩ exchanger attenuates hypoxic and ischemic contractile failure by preserving Ca i 2ϩ homeostasis and point to the functional relevance of upregulation of Na ϩ /Ca 2ϩ exchange in pathological settings where SR transport mechanisms are impaired.
